Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype.

European journal of human genetics : EJHG - 1 Nov 2002

Dagan Efrat, Friedman Eitan, Paperna Tamar, Carmi Nirit, Gershoni-Baruch Ruth

Abstract excerpt

BRCA1/2 mutation carriers are at an increased risk for developing breast and/or ovarian cancer. Yet, the genetic and environmental factors that govern the phenotypic expression of mutant BRCA1/2 alleles remain elusive. The CAG repeat within exon 1 of the androgen receptor (AR) gene is reportedly associated with breast cancer phenotype in BRCA1 mutation carriers. Two hundred and twenty seven BRCA1/2 mutation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Genotype

Share to Israel

Share to Ovarian Neoplasms

Share to Receptors, Androgen

Share to Trinucleotide Repeats

Source

Identifiers

PMID: 12404104
DOI: 10.1038/sj.ejhg.5200880

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype.PMID 12404104Read ↗

Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer.Semantic proximity Read ↗

The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series.Semantic proximity Read ↗

Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility.Semantic proximity Read ↗

CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers.Semantic proximity Read ↗

The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancers.Semantic proximity Read ↗

Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer.Semantic proximity Read ↗

Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat.Semantic proximity Read ↗

Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years.Semantic proximity Read ↗

Androgen receptor gene CAG repeat polymorphism and breast cancer risk in Iranian women: a case-control study.Semantic proximity Read ↗

The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.Semantic proximity Read ↗

FMR1 CGG allele length in Israeli BRCA1/BRCA2 mutation carriers and the general population display distinct distribution patterns.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.